Showing 1 to 7 of 7 results
New Compound Shows Promise in Targeting Cancer Metastasis
French biochemist Raphael Rodriguez developed Fentomycin-1, a compound that targets cancer metastasis by triggering ferroptosis, showing promising results in lab tests against various cancers, including pancreatic, breast, and sarcoma cancers.
New Compound Shows Promise in Targeting Cancer Metastasis
French biochemist Raphael Rodriguez developed Fentomycin-1, a compound that targets cancer metastasis by triggering ferroptosis, showing promising results in lab tests against various cancers, including pancreatic, breast, and sarcoma cancers.
Progress
40% Bias Score
Common Pain Relievers Show Promise in Cancer Prevention and Treatment
Studies show common pain relievers like aspirin, ibuprofen, and diclofenac may prevent cancer recurrence by inhibiting the enzyme cyclooxygenase-1, reactivating T-cells to destroy micrometastases, with effectiveness varying across cancer types and patient genetic factors, although potential side eff...
Common Pain Relievers Show Promise in Cancer Prevention and Treatment
Studies show common pain relievers like aspirin, ibuprofen, and diclofenac may prevent cancer recurrence by inhibiting the enzyme cyclooxygenase-1, reactivating T-cells to destroy micrometastases, with effectiveness varying across cancer types and patient genetic factors, although potential side eff...
Progress
40% Bias Score
Rostov Man's Mole Injury Leads to Melanoma Diagnosis
A 27-year-old Rostov resident's sudden seizures led to the discovery of melanoma metastases, possibly triggered by a previous mole injury; this highlights the importance of early detection and regular dermatological check-ups.
Rostov Man's Mole Injury Leads to Melanoma Diagnosis
A 27-year-old Rostov resident's sudden seizures led to the discovery of melanoma metastases, possibly triggered by a previous mole injury; this highlights the importance of early detection and regular dermatological check-ups.
Progress
52% Bias Score
Mother of Four Battles Stage 4 Melanoma After Delayed Diagnosis
Kelly Heather, 38, from Kent, UK, is battling stage 4 metastatic melanoma after a dark line on her fingernail, initially dismissed, proved to be aggressive skin cancer that spread to her brain; her case highlights the importance of early detection and persistent advocacy for additional testing in ca...
Mother of Four Battles Stage 4 Melanoma After Delayed Diagnosis
Kelly Heather, 38, from Kent, UK, is battling stage 4 metastatic melanoma after a dark line on her fingernail, initially dismissed, proved to be aggressive skin cancer that spread to her brain; her case highlights the importance of early detection and persistent advocacy for additional testing in ca...
Progress
48% Bias Score
Curie Institute Researcher Develops Novel Cancer Therapy Targeting Iron-Dependent Metastasis
Raphaël Rodriguez, a CNRS research director at the Curie Institute, discovered that metastatic cancer cells' high iron and copper ion demand makes them vulnerable to oxidation, leading to the development of a molecule inducing 'ferropoptosis', a novel therapeutic approach published in Nature.
Curie Institute Researcher Develops Novel Cancer Therapy Targeting Iron-Dependent Metastasis
Raphaël Rodriguez, a CNRS research director at the Curie Institute, discovered that metastatic cancer cells' high iron and copper ion demand makes them vulnerable to oxidation, leading to the development of a molecule inducing 'ferropoptosis', a novel therapeutic approach published in Nature.
Progress
36% Bias Score
Aspirin Found to Inhibit Cancer Spread by Boosting Immune Response
Research published in Nature reveals how aspirin inhibits thromboxane A2 (TXA2), a clotting factor suppressing T cells, thus potentially preventing cancer spread; clinical trials are underway, but experts advise consulting a doctor before using aspirin for cancer treatment.
Aspirin Found to Inhibit Cancer Spread by Boosting Immune Response
Research published in Nature reveals how aspirin inhibits thromboxane A2 (TXA2), a clotting factor suppressing T cells, thus potentially preventing cancer spread; clinical trials are underway, but experts advise consulting a doctor before using aspirin for cancer treatment.
Progress
40% Bias Score
Spiky Tumor Structures Identified as Key Driver of Cancer Metastasis
Scientists discovered that aggressive breast and melanoma tumors have spiky structures that facilitate cancer spread, potentially leading to new treatments that prevent metastasis by targeting these spikes.
Spiky Tumor Structures Identified as Key Driver of Cancer Metastasis
Scientists discovered that aggressive breast and melanoma tumors have spiky structures that facilitate cancer spread, potentially leading to new treatments that prevent metastasis by targeting these spikes.
Progress
40% Bias Score
Showing 1 to 7 of 7 results